WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr | ₹1,012 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹1,072 Cr |
Mar2022 | ₹934 Cr |
Mar2021 | ₹889 Cr |
Mar2020 | ₹1,012 Cr |
How is Contingent Liabilities of WANBURY Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | -94.40 | |
Mar2023 | ₹1,072 Cr | 14.78 | |
Mar2022 | ₹934 Cr | 5.01 | |
Mar2021 | ₹889 Cr | -12.14 | |
Mar2020 | ₹1,012 Cr | - |
Compare Contingent Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹775.6 Cr | -1.7% | -11.6% | 65.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.7% |
-11.6% |
65.4% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses